https://www.insurerbrain.com/w/index.php?action=history&feed=atom&title=Definition%3AMarket_concentration_%28insurance%29 2026-04-30T09:04:14Z Revision history for this page on the wiki MediaWiki 1.43.8 https://www.insurerbrain.com/w/index.php?title=Definition:Market_concentration_(insurance)&diff=10153&oldid=prev 2026-03-11T06:58:12Z

<p>Bot: Creating new article from JSON</p> <p><b>New page</b></p><div>📊 &#039;&#039;&#039;Market concentration (insurance)&#039;&#039;&#039; refers to the degree to which a small number of [[Definition:Insurance carrier | insurers]], [[Definition:Reinsurance | reinsurers]], or intermediaries dominate a given line of business, geographic territory, or distribution channel. Unlike many industries where concentration is measured at a single national level, insurance markets are often segmented by product — [[Definition:Workers&#039; compensation insurance | workers&#039; compensation]], [[Definition:Directors and officers liability insurance | D&amp;O]], [[Definition:Cyber insurance | cyber]] — and by jurisdiction, meaning a market can appear competitive nationally yet be highly concentrated in individual states or specialty niches.<br /> <br /> ⚙️ Regulators and competition authorities assess concentration using quantitative tools such as the [[Definition:Herfindahl-Hirschman Index (HHI) | Herfindahl-Hirschman Index]] and market-share thresholds drawn from statutory filings and [[Definition:Annual statement | annual statements]] submitted to the [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]]. When a proposed [[Definition:Insurance M&amp;A | merger or acquisition]] would push concentration past certain benchmarks in a defined product-geography cell, the [[Definition:Federal Trade Commission (FTC) review | FTC]], [[Definition:Department of Justice (DOJ) antitrust review | DOJ]], or state [[Definition:Insurance regulator | insurance regulators]] may demand remedies — forcing the parties to divest [[Definition:Book of business | books of business]], release [[Definition:Managing general agent (MGA) | MGAs]] from exclusive arrangements, or carve out specific underwriting operations before the deal can close.<br /> <br /> 💡 Understanding where concentration risks lie is essential for carriers pursuing growth through acquisition and for [[Definition:Private equity | private equity]] sponsors assembling insurance platforms. High concentration can translate into pricing power for incumbents, but it also attracts regulatory scrutiny and can limit the pool of willing [[Definition:Reinsurance | reinsurance]] partners, who may view an overly dominant cedant as a portfolio-concentration risk of their own. Strategic planning around [[Definition:Market entry | market entry]], product expansion, and [[Definition:Cross-border M&amp;A (insurance) | cross-border M&amp;A]] all depend on a clear-eyed assessment of concentration dynamics.<br /> <br /> &#039;&#039;&#039;Related concepts:&#039;&#039;&#039;<br /> {{Div col|colwidth=20em}}<br /> * [[Definition:Herfindahl-Hirschman Index (HHI)]]<br /> * [[Definition:Competitive impact statement]]<br /> * [[Definition:Federal Trade Commission (FTC) review]]<br /> * [[Definition:Department of Justice (DOJ) antitrust review]]<br /> * [[Definition:Insurance M&amp;A]]<br /> * [[Definition:Antitrust law]]<br /> {{Div col end}}</div>

PlumBot